<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00538044</url>
  </required_header>
  <id_info>
    <org_study_id>Gan1</org_study_id>
    <secondary_id>Anzhen1</secondary_id>
    <nct_id>NCT00538044</nct_id>
  </id_info>
  <brief_title>Simvatstatin Used to Treat Pulmonary Hypertension</brief_title>
  <official_title>the Clinical Research Using Simvastatin as a Medication to Treat Advanced Secondary Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      we try to use simvastatin in the treatment of advanced pulmoary hypertension secondary to
      congenital heart disease or chronic pulmonary embolism before and after the operation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      advanced pulmonary hypertension is refractory to the medication in use nowaday, especially
      pulmonary hypertension secondary to congenital heart disease or chronic pulmonary embolism.It
      is revealed that statins may intefere the pathogenisis of the pulmonary hypertension in many
      key poing, such as improving apotosis or inhiting the proliferation of pulmonary vascular
      smooth muscle cell. so we try to use simvastatin in the treatment of advanced pulmoary
      hypertension secondary to congenital heart disease or chronic pulmonary embolism before and
      after the operation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the simvastatin can alleviate pulmonary hypertension</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>pulmonary pressure</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>simvastatin can highten the perioperative and long term survaval rate and the living quality</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Hypertension, Pulmonary</condition>
  <arm_group>
    <arm_group_label>1simvastatin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>before the operation, the patient start the simvastatin medication on the dosage of 40mg per day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2contral group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>just do routin operation with no use of simvastatin, other medication is exact the same as the simvastatin group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>simvastatin</intervention_name>
    <description>medication with simvastation on the dosage of 40mg per day before the operation and all the time after the operation</description>
    <arm_group_label>1simvastatin group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pasp&gt;50mmHg

        Exclusion Criteria:

          -  pasp&lt;50mmhg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huili Gan, MD,Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Beijing Anzehn Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huili Gan, MD,Ph.D.</last_name>
    <phone>13001277863</phone>
    <email>ganhuili@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Huili Gan, MD, Ph.D.</last_name>
      <phone>861013001277863</phone>
      <email>ganhuili@hotamail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2007</study_first_submitted>
  <study_first_submitted_qc>October 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2007</study_first_posted>
  <last_update_submitted>October 1, 2007</last_update_submitted>
  <last_update_submitted_qc>October 1, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2007</last_update_posted>
  <keyword>pulmonary hypertension</keyword>
  <keyword>simvastatin</keyword>
  <keyword>advanced pulmonary hypertension secondary to congenital heart disease</keyword>
  <keyword>advanced pulmonary hypertension secondary to chronic pulmonary embolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

